

share
3,3',19-Tris(Acetyloxy)-7,8-Dihydro-β,ε-Caroten-8-One CAS NO 33474-10-1
Unit Price:
CAS No.:33474-10-1
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
3,3',19-Tris(Acetyloxy)-7,8-Dihydro-β,ε-Caroten-8-One is a specialized, high-purity carotenoid derivative with the CAS number 33474-10-1. This compound is valued for its role as a critical intermediate in the synthesis of complex bioactive molecules and fine chemicals. It is primarily sought by research institutions and manufacturers in the pharmaceutical, nutraceutical, and advanced organic synthesis sectors.
Application
- Pharmaceutical Intermediate: A key building block in the research and development of novel therapeutic agents, particularly in retinoid and carotenoid-based drug discovery.
- Nutraceutical Research: Used in the study and synthesis of advanced carotenoid derivatives with potential health benefits.
- Fine Chemical Synthesis: Serves as a sophisticated precursor for synthesizing complex organic molecules in laboratory and pilot-scale production.
- Biochemical Research: Employed as a standard or reagent in studies investigating carotenoid metabolism, oxidation, and biological activity.
- Cosmetic Ingredient Development: Investigated for use in high-end skincare formulations for its potential antioxidant properties and role in vitamin A synthesis pathways.
Basic Information
| Product Name | 3,3',19-Tris(Acetyloxy)-7,8-Dihydro-β,ε-Caroten-8-One |
| CAS No. | 33474-10-1 |
| Molecular Formula | C42H54O7 |
| Molecular Weight | 670.88 g/mol |
| Synonyms | 3,3',19-Triacetoxy-7,8-dihydro-β,ε-caroten-8-one; 8'-Apo-β-caroten-8'-al, 3,3',19-triacetate; 3,3',19-Triacetyloxy-7,8-dihydro-β,ε-caroten-8-one; Trisacetyloxy-dihydrocarotenone; Carotenoid derivative 33474-10-1; 8'-Apo-β-caroten-8'-al triacetate; β,ε-Caroten-8-one, 3,3',19-tris(acetyloxy)-7,8-dihydro- |
| EINECS | Contact for details |
Quality Control
Our 3,3',19-Tris(Acetyloxy)-7,8-Dihydro-β,ε-Caroten-8-One is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for research and synthesis applications. Certificates of Analysis (COA) documenting all critical parameters are available upon request.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is light-sensitive and should be handled under an inert atmosphere when appropriate to prevent degradation.
Specification
| Item | Specification |
|---|---|
| Appearance | Orange to red crystalline powder |
| Identification (IR) | Conforms to structure |
| Purity (HPLC) | ≥ 95.0% |
| Loss on Drying | ≤ 2.0% |
| Residue on Ignition | ≤ 0.5% |
| Heavy Metals | ≤ 20 ppm |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Parkeol CAS NO 514-45-4


(S)-(-)-Limonene CAS NO 5989-54-8


Terpinen-4-Ol CAS NO 562-74-3


Cedrene CAS NO 11028-42-5


β-Pinene CAS NO 127-91-3


3-Carene CAS NO 13466-78-9


Farnesene CAS NO 502-61-4


Glycyrrhizic Acid CAS NO 1405-86-3


Asiaticoside CAS NO 16830-15-2


Zerumbone CAS NO 471-05-6


Valerenic Acid CAS NO 3569-10-6


Asiatic Acid CAS NO 464-92-6


Cantharidin CAS NO 56-25-7


Madecassic Acid CAS NO 18449-41-7


Squalene CAS NO 111-02-4


D-(+)-Camphoric Acid CAS NO 124-83-4


Taraxerol CAS NO 127-22-0


Pimaric Acid CAS NO 127-27-5


1,2,3,4,4A,4B,5,6,7,9,10,10A-Dodecahydro-7-Isopropyl-1,4A-Dimethylphenanthren-1-Methanol CAS NO 127-36-6


Nopol CAS NO 128-50-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






